Nevada
|
20-3464383
|
State
of Incorporation
|
IRS
Employer Identification No.
|
Large accelerated filer
|
o
|
Accelerated filer
|
o
|
|
Non-accelerated filer
|
o
|
Small
Business Issuer
|
x
|
|
||||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
CERTIFICATIONS | ||||
Exhibit 31 – Management certification | ||||
Exhibit 32 – Sarbanes-Oxley Act |
•
|
3X
the kick of the typical canned energy drink in a small 2oz.
bottle!
|
•
|
Metabolizes
faster than canned energy
drink
|
•
|
Zero carbs, Zero
grams of sugar, only 8 calories per
serving
|
•
|
No
crash- as associated with all sugar based energy
drinks
|
•
|
The
strongest / longest lasting energy shot available on the
market
|
•
•
|
Voted
the #1 tasting energy shot in the category at the 2007 NACS
Show!
Available
in Berry and Limon
|
Solana
Beach
|
Huntington
Beach
|
Omaha
|
Total
|
|||||||||||||
2007
|
$ | 1,860 | $ | 2,875 | $ | 3876 | $ | 8,521 | ||||||||
2008
|
$ | 1,860 | $ | 2,875 | $ | 3,876 | $ | 8,521 |
Periods
|
High
|
Low
|
|||||
Fiscal
Year 2008
|
|||||||
First
Quarter (January – March 2008)
|
$ | 1.50 | $ | 1.50 | |||
Second
Quarter (April – June 2008)
|
$ | .92 | $ | .91 | |||
Third
Quarter (July – September 2008)
|
$ | .95 | $ | .55 | |||
Fourth
Quarter (October – December 2008)
|
$ | .62 | $ | .21 | |||
Fiscal
Year 2007
|
|||||||
First
Quarter (January – March 2007)
|
$ | 00. | $ | . 00 | |||
Second
Quarter (April – June 2007)
|
$ | . 00 | $ | . 00 | |||
Third
Quarter (July – September 2007)
|
$ | 1.75 | $ | 3.00 | |||
Fourth
Quarter (October – December 2007)
|
$ | 3.25 | $ | 3.00 |
Years
Ended
|
Stock
issued for Cash
|
Cash
Received
|
Stock
for Conversion of Debt
|
Stock
issued for Stock Split
|
Stock
issued and cancelled for services
|
||||||||||||||
December
31, 2007
|
2,014,000 | $ | 1,651,000 | 1,878,600 | 9,067,225 | 2,517,625 | |||||||||||||
December
31, 2008
|
4,301,933 | $ | 4,157,477 | - | - | 1,766,022 |
|
|
|
|
||||||
Date issued |
Warrants
Issued
|
Strike
Price
|
Date
Expired
|
||||||
January
31, 2008
|
1,875,000 | 1.50 |
January
31, 2013
|
||||||
June
30, 2008
|
1,952,359 | 1.25 |
June
30, 2013
|
||||||
June
30, 2008
|
634,516 | 1.10 |
June
30, 2013
|
||||||
December
31, 2008
|
1,900,000 | 0.375 |
December
31, 2013
|
||||||
Total
Warrants Issued
|
6,361,875 |
December
31,
|
||||||||
2008
|
2007
|
|||||||
Revenues
|
$ | 2,530,424 | $ | 11,531 | ||||
Cost
of Deliverables
|
(1,617,503 | ) | (7,845 | ) | ||||
Operating
and Other Expenses
|
(7,538,912 | ) | (3,965,287 | ) | ||||
Net
Loss
|
$ | (6,625,991 | ) | $ | (3,961,601 | ) | ||
Balance
Sheet Data:
|
December
31,
|
|||||||
2008
|
2007
|
|||||||
Current
Assets
|
$ | 2,956,791 | $ | 1,219,556 | ||||
Total
Assets
|
5,361,707 | 1,314,960 | ||||||
Current
Liabilities
|
2,175,194 | 30,253 | ||||||
Non
Current Liabilities
|
118,102 | - | ||||||
Total
Liabilities
|
2,293,296 | 30,253 | ||||||
Working
Capital (Deficit)
|
781,597 | 1,189,303 | ||||||
Shareholders'Equity
(Deficit)
|
$ | 3,068,411 | $ | 1,284,707 |
TABLE OF CONTENTS
|
Page
|
BOND
LABORATORIES, INC.
|
||||||||
CONSOLIDATED
BALANCE SHEETS
|
||||||||
|
December
31,
|
|||||||
ASSETS:
|
2008
|
2007
|
||||||
CURRENT
ASSETS
|
||||||||
Cash
|
$ | 263,379 | $ | 590,197 | ||||
Accounts
receivables - net
|
428,790 | 4,532 | ||||||
Inventory
|
1,984,245 | - | ||||||
Notes
receivables
|
250,137 | - | ||||||
Prepaid
expenses and other current assets
|
30,240 | 624,527 | ||||||
Total
current assets
|
2,956,791 | 1,219,256 | ||||||
PROPERTY
AND EQUIPMENT, net
|
238,328 | 92,977 | ||||||
Intangibles
assets, net
|
2,160,860 | - | ||||||
Deposits
|
5,728 | 2,727 | ||||||
TOTAL
ASSETS
|
$ | 5,361,707 | $ | 1,314,960 | ||||
LIABILITIES
AND STOCKHOLDERS' EQUITY:
|
||||||||
CURRENT
LIABILITIES:
|
||||||||
Accounts
payable
|
$ | 950,947 | $ | 30,000 | ||||
Accrued
expenses and other liabilities
|
238,617 | 253 | ||||||
Note
payable - affiliate
|
50,769 | - | ||||||
Note
payable - current
|
934,861 | - | ||||||
Total
current liabilities
|
2,175,194 | 30,253 | ||||||
Notes
payable - long term
|
118,102 | - | ||||||
TOTAL
LIABILITIES
|
2,293,296 | 30,253 | ||||||
CONTINGENCIES
AND COMMITMENTS
|
||||||||
STOCKHOLDERS'
EQUITY:
|
||||||||
Preferred
stock series A, $.01 par value, 10,000,000 shares authorized; 5,659,477
and 5,000,000 issued and outstanding as of December 31, 2008 and 2007,
respectively
|
56,595 | 50,000 | ||||||
Preferred
stock series B, $.01 par value, 1,000 sharesauthorized; none issued and
outstanding, 10% Cumulative Perpetual with a Stated Value of $10,000 per
share; as of December 31, 2008 and 2007, respectively
|
- | - | ||||||
Common
stock, $.01 par value, 75,000,000 shares authorized; 25,839,928 and
20,431,450 issued and outstanding as of December 31, 2008 and 2007,
respectively
|
258,399 | 204,314 | ||||||
Additional
paid-in capital
|
12,306,023 | 5,807,008 | ||||||
Common
stock subscribed, 7,500,000
|
1,249,792 | - | ||||||
Preferred
A stock subscribed, 4,000,000
|
600,000 | - | ||||||
Preferred
B stock subscribed, 125
|
208 | - | ||||||
Accumulated
deficit
|
(11,402,606 | ) | (4,776,615 | ) | ||||
Total
stockholders' equity
|
3,068,411 | 1,284,707 | ||||||
TOTAL
LIABILITIES AND STOCKHOLDERS' EQUITY
|
$ | 5,361,707 | $ | 1,314,960 |
BOND
LABORATORIES, INC.
|
||||||||
CONSOLIDATED
STATEMENT OF OPERATIONS
|
||||||||
FOR
THE YEARS ENDED DECEMBER 31, 2008 AND 2007
|
||||||||
2008
|
2007
|
|||||||
Revenue
|
$ | 2,530,424 | $ | 11,530 | ||||
Total
|
2,530,424 | 11,530 | ||||||
Cost
of Goods Sold
|
1,617,503 | 7,845 | ||||||
Gross
Profits
|
912,921 | 3,685 | ||||||
OPERATING
EXPENSES:
|
||||||||
General
and administrative
|
4,275,707 | 3,450,557 | ||||||
Selling
and marketing
|
3,108,936 | 197,736 | ||||||
Depreciation
and amortization
|
69,553 | 14,596 | ||||||
Research
and development
|
120,634 | 272,469 | ||||||
Total
operating expenses
|
7,574,830 | 3,935,358 | ||||||
OPERATING
LOSS
|
(6,661,909 | ) | (3,931,673 | ) | ||||
OTHER
(INCOME) AND EXPENSES
|
||||||||
Interest
expense
|
8,566 | 42,631 | ||||||
Interest
income
|
(36,984 | ) | (6,702 | ) | ||||
Rental
income
|
(7,500 | ) | (6,000 | ) | ||||
Total
other (income) expense
|
(35,918 | ) | 29,929 | |||||
NET
LOSS
|
$ | (6,625,991 | ) | $ | (3,961,602 | ) | ||
NET
LOSS PER SHARE:
|
||||||||
Basic
|
$ | (0.28 | ) | $ | (0.43 | ) | ||
Diluted
|
$ | (0.22 | ) | $ | (0.38 | ) | ||
Basic
|
23,657,487 | 9,131,404 | ||||||
Diluted
|
30,019,362 | 10,370,004 |
BOND
LABORATORIES, INC.
|
||||||||||||||||||||||||||||||||||||
CONSOLIDATED
STATEMENT OF STOCKHOLDER'
EQUITY
|
||||||||||||||||||||||||||||||||||||
FOR
THE YEARS ENDED DECEMBER 31, 2008 AND 2007
|
||||||||||||||||||||||||||||||||||||
\
------- Preferred Stock --------\
|
|
|
|
|
||||||||||||||||||||||||||||||||
Common
Stock
|
Preferred
A
|
Preferred
B
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Shares
|
Amount
|
Add
-
itional
Paid-in
|
Common
Stock
Sub-scribed
|
Preferred
A
Stock
Sub-scribed
|
Preferred
B
Stock
Sub-scribed
|
Accum-ulated
Deficit
|
Total
|
|||||||||||||||||||||||||
DECEMBER
31, 2006
|
4,954,000 | $ | 49,540 | 5,000,000 | $ | 50,000 | - | $ | - | $ | - | - | $ | - | $ | (815,013 | ) | $ | (715,473 | ) | ||||||||||||||||
Common
stock issued for cash
|
2,014,000 | 20,140 | - | - | - | - | 3,310,301 | - | - | - | 3,330,441 | |||||||||||||||||||||||||
Common
stock issued for services
|
2,917,625 | 29,176 | - | - | - | - | 1,630,860 | - | - | - | 1,660,036 | |||||||||||||||||||||||||
Common
stock issued in a 2 for 1 forward split
|
9,067,225 | 90,672 | - | - | - | - | (90,672 | ) | - | - | - | - | ||||||||||||||||||||||||
Common
stock issued in convertible debt and interest expense
|
1,478,600 | 14,786 | - | - | - | - | 944,133 | - | - | - | 958,919 | |||||||||||||||||||||||||
Warrants
issued 1,238,600 @ $.01
|
12,386 | 12,386 | ||||||||||||||||||||||||||||||||||
Net
loss
|
- | - | - | - | - | - | - | - | - | - | (3,961,602 | ) | ( | 3,961,602 | ) | |||||||||||||||||||||
DECEMBER
31, 2007
|
20,431,450 | $ | 204,314 | 5,000,000 | $ | 50,000 | - | $ | - | $ | 5,807,008 | - | $ | - | $ | - | $ | (4,776,615 | ) | $ | 1,284,707 | |||||||||||||||
Common
stock issued for cash
|
3,642,456 | 36,425 | - | - | - | - | 3,461,575 | - | - | - | - | 3,498,000 | ||||||||||||||||||||||||
Common
stock issued for services
|
1,340,522 | 13,405 | - | - | - | - | 1,531,793 | - | - | - | - | 1,545,198 | ||||||||||||||||||||||||
Common
stock cancelled
|
(1,124,500 | ) | (11,245 | ) | - | - | - | - | 11,245 | - | - | - | - | - | ||||||||||||||||||||||
Common
stock issued in the Asset Purchase Agreement
|
1,550,000 | 15,500 | - | - | - | - | 775,000 | - | - | - | - | 790,500 | ||||||||||||||||||||||||
Cost
of raising capital
|
(250,713 | ) | (250,713 | ) | ||||||||||||||||||||||||||||||||
Preferred
series A shares subscribed not issued 4,000,000 @ $.15
|
600,000 | 600,000 | ||||||||||||||||||||||||||||||||||
Preferred
series B shares subscribed not issued 125@ $.17
|
208 | 208 | ||||||||||||||||||||||||||||||||||
Common
stock subscribed not issued 7,500,000 @ $.17
|
1,249,792 | 1,249,792 | ||||||||||||||||||||||||||||||||||
Preferred
stock issued for cash
|
659,477 | 6,595 | 652,882 | 659,477 | ||||||||||||||||||||||||||||||||
Warrants
issued 636,400 @ $.01 January 31, 2008
|
6,364 | 6,364 | ||||||||||||||||||||||||||||||||||
Warrants
issued 2,586,875 @ $.01 June 30, 2008
|
25,869 | 25,869 | ||||||||||||||||||||||||||||||||||
Warrants
issued 1,900,000 @ $.15 December 31, 2008
|
285,000 | 285,000 | ||||||||||||||||||||||||||||||||||
Net
loss
|
- | - | - | - | - | - | - | - | - | - | (6,625,991 | ) | ( | 6,625,991 | ) | |||||||||||||||||||||
DECEMBER
31, 2008
|
25,839,928 | $ | 258,399 | 5,659,477 | $ | 56,595 | - | $ | - | $ | 12,306,023 | $ | 1,249,792 | $ | 600,000 | $ | 208 | $ | (11,402,606 | ) | $ | 3,068,411 |
BOND
LABORATORIES, INC.
|
||||||||
CONSOLIDATED
STATEMENTS OF CASH FLOWS
|
||||||||
FOR
THE YEARS ENDED DECEMBER 31, 2008 AND 2007
|
||||||||
2008
|
2007
|
|||||||
Net
loss
|
$ | (6,625,991 | ) | $ | (3,961,602 | ) | ||
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
||||||||
Depreciation
and amortization
|
69,553 | 14,596 | ||||||
Common
stock issued for services
|
1,545,198 | 2,509,477 | ||||||
Warrants
issued in conversion of debt
|
- | 12,386 | ||||||
Stock
warrants issued
|
317,233 | - | ||||||
Preferred
series A subscribed not issued
|
600,000 | 26,625 | ||||||
Changes
in operating assets and liabilities:
|
||||||||
Accounts
receivables
|
(424,258 | ) | (4,532 | ) | ||||
Inventory
|
(1,984,245 | ) | - | |||||
Prepaid
expenses
|
594,286 | (24,527 | ) | |||||
Deposits
|
(3,000 | ) | (2,727 | ) | ||||
Accounts
payables
|
920,947 | 15,500 | ||||||
Accrued
liabilities
|
239,133 | 1,257 | ||||||
Net
cash used in operating activities
|
(4,751,144 | ) | (1,413,547 | ) | ||||
CASH
FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
Note
receivable
|
(250,137 | ) | - | |||||
Purchase
of property and equipment
|
(178,279 | ) | - | |||||
Purchase
of intangible asset
|
(1,406,985 | ) | (43,009 | ) | ||||
Net
cash used in investing activities
|
(1,835,401 | ) | (43,009 | ) | ||||
CASH
FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
Proceeds
from the issuances of common stock
|
3,498,000 | 1,651,000 | ||||||
Cost
of raising capital
|
(250,713 | ) | - | |||||
Proceeds
from affiliated note payable
|
50,000 | - | ||||||
Proceeds
preferred B and common stock subscribed
|
1,250,000 | 335,000 | ||||||
Proceeds
from the issuances of preferred A stock
|
659,477 | - | ||||||
Proceeds
from note payable
|
1,052,963 | - | ||||||
Net
cash provided by financing activities
|
6,259,727 | 1,986,000 | ||||||
INCREASE
(DECREASE) IN CASH
|
(326,818 | ) | 529,444 | |||||
CASH,
BEGINNING OF PERIOD
|
590,197 | 60,753 | ||||||
CASH,
END OF PERIOD
|
$ | 263,379 | $ | 590,197 | ||||
Supplemental
disclosure of non-cash investing and financing activities
|
||||||||
Conversion
of debt into common stock
|
$ | - | $ | 815,000 | ||||
Issuance
of common stock for repayment of loan affiliates
|
$ | - | $ | 117,294 | ||||
Issuance
of company stock for prepaid services
|
$ | - | $ | 600,000 | ||||
Issuance
of company stock for accrued liabilities
|
$ | - | $ | 230,000 | ||||
Issuance
of company stock for the assets purchase
|
$ | 790,500 | $ | - |
Asset
Category
|
Depreciation/
Amortization
Period
|
Furniture
and Fixture
|
3
Years
|
Office
equipment
|
3
Years
|
Leasehold
improvements
|
5
Years
|
a.
|
Recognizes
and measures in its financial statements the identifiable assets acquired,
the liabilities assumed, and any noncontrolling interest in the
acquiree.
|
b.
|
Recognizes
and measures the goodwill acquired in the business combination or a gain
from a bargain purchase.
|
c.
|
Determines
what information to disclose to enable users of the financial statements
to evaluate the nature and financial effects of the business
combination.
|
December
31,
|
|||||||
2008
|
2007
|
||||||
Sponsorship
Agreement
|
$ | - | $ | 600,000 | |||
Legal
Retainer
|
30,240 | 5,000 | |||||
ProTab
laboratories retainer
|
- | 19,527 | |||||
Total
|
$ | 30,240 | $ | 624,527 |
December
31,
|
|||||||
2008
|
2007
|
||||||
Finished
goods
|
$ | 1,684,802 | $ | - | |||
Components
|
299,443 | - | |||||
Total
|
$ | 1,984,245 | $ | - |
December
31,
|
||||||||
2008
|
2007
|
|||||||
Equipment
|
$ | 374,115 | $ | 109,148 | ||||
Accumulated
depreciation
|
(135,787 | ) | (16,171 | ) | ||||
Total
|
$ | 238,328 | $ | 92,977 |
2008
|
2007
|
||||||
Secured
promissory note (Fixed Assets) dated October 1, 2008 at an interest rate
of 6.00% per annum until April 1, 2010. Principal and interest
are due in monthly payments of $9,514.27.
|
$ | 145,948 | $ | - | |||
Secured
promissory note (Component Inventory) dated October 1, 2008 at an interest
rate of 6.00% per annum until October 1, 2009. Principal and interest are
due in monthly payments of $25,114.01.
|
244,370 | - | |||||
Secured
promissory note (Installment) dated October 1, 2008 at an interest rate of
6.00% per annum until October 1, 2010. Principal and interest
are due in quarterly payments of $20,381.11.
|
312,645 | - | |||||
Other
notes payable
|
350,000 | - | |||||
Total
of Notes Payable
|
1,052,963 | - | |||||
Less
Current Portion
|
(934,861 | ) | - | ||||
Long-Term
Portion
|
$ | 118,102 | $ | - |
|
Warrants
|
Strike
|
Date
|
||||||
Date
issued
|
Issued
|
Price
|
Expired
|
||||||
January
31, 2008
|
1,875,000 | 1.50 |
January
31, 2013
|
||||||
June
30, 2008
|
1,952,359 | 1.25 |
June
30, 2013
|
||||||
June
30, 2008
|
634,516 | 1.10 |
June
30, 2013
|
||||||
December
31, 2008
|
1,900,000 | 0.375 |
December
31, 2013
|
||||||
Total
Warrants Issued
|
6,361,875 |
Dividend
yield
|
None
|
|||
Volatility
|
0.491
|
|||
Risk
free interest rate
|
4.18
|
%
|
||
Expected
asset life
|
5
years
|
Years
Ended
|
Stock
issued
for
Cash
|
Cash
Received
|
Stock
for
Conversion
of Debt
|
Stock
issued for
Stock
Split
|
Stock
issued
and cancelled
for
services
|
|||||||||||||||
December
31, 2007
|
2,014,000 | $ | 1,651,000 | 1,878,600 | 9,067,225 | 2,517,625 | ||||||||||||||
December
31, 2008
|
4,301,933 | $ | 4,157,477 | - | - | 1,766,022 |
December
31,
|
||||||||
2008
|
2007
|
|||||||
Current:
|
||||||||
Federal
|
$ | - | $ | - | ||||
State
|
- | - | ||||||
- | - | |||||||
Deferred:
|
||||||||
Federal
|
$ | 2,252,837 | $ | 1,536,010 | ||||
State
|
589,713 | 402,173 | ||||||
2,842,550 | 1,938,183 | |||||||
Valuation
allowance
|
(2,842,550 | ) | (1,938,183 | ) | ||||
Provision
benefit for income taxes, net
|
$ | - | $ | - |
December
31,
|
||||||||
2008
|
2007
|
|||||||
Statutory
federal income tax rate
|
34.0 | % | 34.0 | % | ||||
State
income taxes and other
|
8.9 | % | 8.9 | % | ||||
Valuation
allowance
|
(42.9 | %) | (42.9 | %) | ||||
Effective
tax rate
|
- | - |
December
31,
|
||||||||
2008
|
2007
|
|||||||
Net
operating loss carryforward
|
2,842,550 | 1,938,183 | ||||||
Valuation
allowance
|
(2,842,550 | ) | (1,938,183 | ) | ||||
Deferred income tax
asset
|
$ | - | $ | - |
Name
|
Age
|
Title
|
||
Scott
Landow
|
53
|
President
and Chief Executive Officer, Director, Principle Accounting
Officer
|
||
John
Wilson
|
45
|
President
of Fusion Premium Energy, Inc.
|
||
Scott
Solcum
|
40
|
Executive
of Fusion Premium Energy, Inc.
|
||
Ryan
Zink
|
42
|
President
of NDS Nutritional
Products
|
Name
and Principal Position
|
Year
|
Salary ($)
|
Bonus ($)
|
Stock
Awards
($)
|
Option
Awards
($)
|
Non-Equity
Incentive
Plan
Compensation
($)
|
Change
in
Pension
Value
and
Nonqualified
Deferred
Compensation
Earnings
($)
|
All
Other
Compen-sation
($)
|
Total
($)
|
|||||||||||||||||||||
Scott
|
2008
|
120,000 | 0 | 0 | 0 | 0 | 6,000 | 126,000 | ||||||||||||||||||||||
Landow
|
2007
|
120,000 | 0 | 0 | 0 | 0 | 6,000 | 126,000 |
Option
Awards
|
Stock
Awards
|
|||||||||||||||||||||||||||||||||||
Number
of
Securities
Underlying
Unexercised
Options
(#)
Exercisable
|
Number
of
Securities
Underlying
Unexercised
Options
(#)
Unexercisable
|
Equity
Incentive
Plan Awards:
Number
of
Securities
Underlying
Unexercised
Unearned
Options
(#)
|
Option
Exercise
Price
($)
|
Option
Expiration
Date
|
Number of
Shares
or
Units
of
Stock That
Have
Not
Vested
(#)
|
Market
Value of
Shares or
Units
of
Stock That
Have
Not
Vested
($)
|
Equity
Incentive
Plan
Awards:
Number
of
Unearned
Shares,
Units
or
Other
Rights
That
Have
Not
Vested
(#)
|
Equity
Incentive
Plan
Awards:
Market
or
Payout
Value
of
Unearned
Shares,
Units
or
Other
Rights
That
Have
Not
Vested
($)
|
||||||||||||||||||||||||||||
Name
|
||||||||||||||||||||||||||||||||||||
Scott
Landow
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Option
Awards
|
Stock
Awards
|
|||||||
Name
|
|
Number
of Shares Acquired on Exercise (#)
|
|
Value Realized on Exercize
(#)
|
|
Number
of Shares Acquired on Voting (#)
|
|
Value
Realized on Vesting ($)
|
Scott
Landow 2007
|
|
0
|
|
0
|
|
0
|
|
0
|
Scott Landow 2008 | 0 |
0
|
0
|
0
|
Name
|
|
Plan
Name
|
|
Number of
Years
Credited
Service
(#)
|
|
Present
Value
of Accumulated
Benefit
($)
|
|
Payments During Last
Fiscal
Year
($)
|
Scott
Landow
|
|
|
|
0
|
|
0
|
|
0
|
Name
|
Executive
Contributions
in
Last Fiscal Year
($)
|
Registrant
Contributions
in Last
Fiscal
Year
($)
|
Aggregate Earnings
in
Last Fiscal Year
($)
|
Aggregate
Withdrawals /
Distributions
($)
|
Aggregate Balance at
Last
Fiscal Year-End
($)
|
|||||||||||||||
Scott
Landow
|
0 | 0 | 0 | 0 | 0 |
Name
|
Fees
Earned or
Paid in
Cash
($)
|
Stock Awards
($)
|
Option
Awards
($)
|
Non-Equity
Incentive
Plan Compensation
($)
|
Change
in
Pension
Value
and
Nonqualified
Deferred
Compensation
Earnings
($)
|
All
Other Compensation
($)
|
Total
($)
|
|||||||||||||||||||||
Scott
Landow
|
0 | 0 | 0 | 0 | 0 | 0 | 0 |
Name
|
Year
|
Perquisites
and
Other
Personal
Benefits
($)
|
Tax
Reimbursements
($)
|
Insurance
Premiums
($)
|
Company
Contributions
to Retirement
and
401(k)
Plans
($)
|
Severance
Payments /
Accruals
($)
|
Change
in Control
Payments /
Accruals
($)
|
Total ($)
|
||||||||||||||||||||||
Scott
|
2007
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
Landow |
2008
|
0 | 0 | 0 | 0 | 0 | 0 | 0 |
Name
|
Year
|
Personal Use of
Company
Car/Parking
|
Financial Planning/
Legal
Fees
|
Club Dues
|
Executive Relocation
|
Total Perquisites
and
Other Personal
Benefits
|
||||||||||||||||||||||
Scott | 2007 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
Landow |
2008
|
0 | 0 | 0 | 0 | 0 |
Name
|
Benefit
|
Before
Change in
Control
Termination
w/o Cause
or for
Good
Reason
|
After Change in
Control
Termination w/o Cause
or
for Good
Reason
|
Voluntary
Termination
|
Death
|
Disability
|
Change in
Control
|
|||
Scott
Landow
|
Basic salary
|
- |
Name
and Address of Owner
|
Title
of Class
|
Number
of
Shares
Owned
(1)
|
Percentage
of
Class
|
||||||
Scott
Landow
777
South Highway 101, Suite 215
Solana
Beach, CA 92975
(2)
|
Common
Stock
|
6,280,400 | 19. | % | |||||
All
Officers and Directors
As
a Group (1 persons)
|
Common
Stock
|
6,280,400 | 19. | % | |||||
Small
World Traders
(3)
777
South Highway 101, Suite 215
Solana
Beach, CA 92975
|
Common
Stock
|
2,740,000 | 8.27 | % | |||||
WWFD
LLC
(4)
777
South Highway 101, Suite 215
Solana
Beach, CA 92975
|
Common
Stock
|
2,950,000
|
8.9
|
% | |||||
Vicis
Capital Master Fund
(5)
445
Park Ave 16
th
Floor
New
York, NY 10022
|
Common Stock | 9,840,523 | 29.7 | % |
3.1
|
Articles
of Incorporation
(1)
|
|
3.2
|
Amendments
to Articles of Incorporation
(1)
|
|
3.1
|
Bylaws
of the Corporation
(1)
|
|
10.1
|
Employment
Agreement Scott Landow
(1)
|
|
10.2
|
Securities
Purchase Agreement
(1)
|
|
14.1
|
Code
of Ethics
(2)
|
|
21
|
Subsidiaries
(2)
|
|
31.1
|
Certification
of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley
Act.
(2)
|
|
31.2
|
Certification
of Principal Financial and Accounting Officer Pursuant to Section 302 of
the Sarbanes-Oxley Act.
(2)
|
|
32.1
|
Certification
of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley
Act.
(2)
|
|
32.2
|
Certification
of Chief Accounting Officer Pursuant to Section 906 of the Sarbanes-Oxley
Act.
(2)
|
Registrant
Date:
March 27, 2009
|
Bond
Laboratories, Inc.
By:
/s/ Scott
Landow
|
|
Scott Landow
|
||
Chairman, Chief Executive Officer (Principle Executive
Officer)
|
Date:
March 27, 2009
|
By:
/s/ Scott
Landow
|
|
Scott Landow
|
||
Principle Financial Officer
|
Date:
March 27, 2009
|
By:
/s/ Scott
Landow
|
|
Scott Landow
|
||
Chairman, Chief Executive Officer (Principle Executive
Officer),
Director
Principle Financial Officer
|
1.
|
I
have reviewed this annual report on Form 10-K of Bond
Laboratories, Inc.;
|
2.
|
Based
on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this
report;
|
b.
|
Designed
such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principles;
|
a.
|
b.
|
Any
fraud, whether or not material, that involves management or other
employees who have a significant role in the small business issuer's
internal control over financial
reporting.
|
1.
|
I
have reviewed this annual report on Form 10-K of Bond
Laboratories, Inc.;
|
2.
|
Based
on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this
report;
|
3.
|
Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the small
business issuer as of, and for, the periods presented in this
report;
|
4.
|
The
small business issuer's other certifying officer(s) and I are responsible
for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the small business issuer and
have:
|
a.
|
Designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure
that material information relating to the small business issuer, including
its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being
prepared;
|
b.
|
Designed
such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principles;
|
c.
|
Evaluated
the effectiveness of the small business issuer's disclosure controls and
procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation;
and
|
d.
|
Disclosed
in this report any change in the small business issuer's internal control
over financial reporting that occurred during the small business issuer's
most recent fiscal quarter (the small business issuer's fourth fiscal
quarter in the case of an annual report) that has materially affected, or
is reasonably likely to materially affect, the small business issuer's
internal control over financial reporting;
and
|
5.
|
The
small business issuer's other certifying officer(s) and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the small business issuer's auditors and the audit committee
of the small business issuer's board of directors (or persons performing
the equivalent functions):
|
a.
|
All
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the small business issuer's ability
to record, process, summarize and report financial information;
and
|
b.
|
Any
fraud, whether or not material, that involves management or other
employees who have a significant role in the small business issuer's
internal control over financial
reporting.
|